Overview

Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process in Healthy Japanese

Status:
Completed
Trial end date:
2005-02-26
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. The aim of this trial is to compare insulin aspart produced by current process and the NN2000 process in healthy Japanese subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin, Globin Zinc